U
Acro Biomedical Co., Ltd. ACBM
$0.0007 -$0.1043-99.33%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
ACBM market cap represents 0.00% of the sector.
Valuation
ACBM
Low
ACBM
Sector Average
High
Market Cap
42.03K
< 42.02K
> 16.25B
Enterprise Value
131.31K
< 0.00
> 18.37B
Price/Earnings (TTM)
0.00
< -10.00
> 10.00
Earnings Per Share Growth (TTM)
1.41%
< -50.00%
> 10.00%
Price/Earnings To Growth (TTM)
--
0.00
12.21
Price/Sales (TTM)
0.13
< 0.000
> 440.00
Price/Book (Q)
0.12
< 0.00
> 20.00
Enterprise Value/Revenue (TTM)
0.36
< 0.00
> 210.00
Enterprise Value/EBITDA (TTM)
--
-6,712.91
4,540.64
Enterprise Value/EBIT (TTM)
-0.01
< -10.00
> 10.00
Dividends and Shares
ACBM
Low
ACBM
Sector Average
High
Shares Outstanding
63.91M
< 50.00M
> 240.00M
Dividend Per Share (Most Recent)
--
0.00
2.38
Dividend Per Share (TTM)
--
0.00
9.13
Dividend Yield (TTM)
--
0.00%
7.67%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
ACBM
Low
ACBM
Sector Average
High
Beta
-1.21
< -10.00
> 0.00
1-Month Total Return
0.00%
< -20.00%
> 0.00%
3-Month Total Return
0.00%
< -20.00%
> 0.00%
6-Month Total Return
0.00%
< 0.00%
> 10.00%
Year to Date Total Return
0.00%
< -20.00%
> 0.00%
1-Year Total Return
-99.33%
-99.69%
> 10.00%
2-Year Total Return
-99.98%
-99.99%
> 440.00%
3-Year Total Return
-99.99%
-100.00%
> 0.00%
5-Year Total Return
-99.98%
-100.00%
> 220.00%
Profitability
ACBM
Low
ACBM
Sector Average
High
Operating Margin (TTM)
-4,206.38%
< -13,030.00%
> -3,250.00%
Profit Margin (TTM)
-4,207.19%
< -12,560.00%
> -3,130.00%
Management Effectiveness
ACBM
Low
ACBM
Sector Average
High
Return on Assets (TTM)
-1,566.43%
-633.94%
> -10.00%
Return on Equity (TTM)
--
0.26%
824.40%
Income Statement
ACBM
Low
ACBM
Sector Average
High
Revenue (TTM)
360.00K
< 0.00
> 12.30B
Total Revenue (TTM)
360.00K
< 0.00
> 12.49B
Total Revenue Growth (Q YOY)
--
-109.18%
206,582.61%
Revenue Per Share (TTM)
0.01
< 0.00
> 200.00
Gross Profit (TTM)
64.00K
< 0.00
> 3.74B
EBITDA (TTM)
--
-3.76B
36.39B
EBIT (TTM)
-15.14M
< -20.00M
> 730.00M
Net Income (TTM)
-15.15M
< -20.00M
> 270.00M
Net Income Avl. to Common (TTM)
-15.15M
< -20.00M
> 270.00M
Earnings Growth (Q YOY)
20.04%
< -290.00%
> 30.00%
EPS Diluted (TTM)
-0.25
< -5,460.00
> 0.00
EPS Diluted Growth (Q YOY)
20.12%
< -20.00%
> 30.00%
Balance Sheet
ACBM
Low
ACBM
Sector Average
High
Cash and Short-Term Inv. (Q)
2.70K
45.00K
> 1.38B
Cash Per Share (Q)
0.00
0.00
> 200.00
Total Current Assets (Q)
526.20K
18.60K
> 3.46B
Total Assets (Q)
539.10K
280.10K
> 9.79B
Total Current Liabilities (Q)
199.50K
110.30K
> 2.57B
Total Debt (Q)
92.00K
0.00
> 3.15B
Total Liabilities (Q)
199.50K
117.90K
> 6.15B
Total Common Equity (Q)
339.70K
< 0.00
> 3.55B
Total Preferred Equity (Q)
--
0.00
920.42M
Total Equity (Q)
339.70K
< 0.00
> 3.65B
Current Ratio (Q)
2.638
0.009
> 20.000
Book Value Per Share (Q)
0.01
< 0.00
> 2,170.00
Cash Flow
ACBM
Low
ACBM
Sector Average
High
Cash from Operations (TTM)
-67.20K
< -10.00M
> 730.00M
Cash from Investing (TTM)
--
-21.35B
3.43B
Cash from Financing (TTM)
57.60K
< -190.00M
> 10.00M
Net Change in Cash (TTM)
-9.30K
< -40.00M
> 0.00
Levered Free Cash Flow (TTM)
5.61M
< 0.00
> 540.00M
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the sector.
Weiss Ratings